Results 171 to 180 of about 191,380 (292)
Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series. [PDF]
Li Y, Yang Y, Zhu Y, Zhu R.
europepmc +1 more source
ABSTRACT Differentiation syndrome (DS) and Sweet syndrome (SS) are inflammatory complications mediated by cytokine dysregulation, classically associated with therapies that promote myeloid differentiation or cytokine release. While DS has been primarily linked to all‐trans retinoic acid (ATRA) and IDH inhibitors, recent evidence suggests that ...
Katerina Grafanaki +6 more
wiley +1 more source
A case of steroid-induced mania following lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS): a cautionary tale. [PDF]
Te B, Tam E, Au S.
europepmc +1 more source
Hell's Itch: A Self‐Case Report
ABSTRACT Hell's itch is a severely distressing dermatological condition characterized by the onset of incessant itching and intolerable pain 2–3 days post‐sunburn. It is underdiagnosed and underreported, and no definitive management framework has yet been developed.
Kai Peter Moors, Willem I. Visser
wiley +1 more source
Liver transplantation, 1980, with particular reference to cyclosporin-A. [PDF]
Iwatsuki, S +6 more
core
Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series. [PDF]
Deng M +6 more
europepmc +1 more source
ABSTRACT This study evaluated the prognostic value of the C‐PLAN index in advanced esophageal squamous cell carcinoma (ESCC) patients receiving immune checkpoint inhibitor (ICI) therapy. A retrospective analysis of 241 eligible patients treated during February 2020 to January 2023 was conducted.
Yi Zhou +5 more
wiley +1 more source
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu +5 more
wiley +1 more source
Effectiveness and safety analysis of initial treatment with belimumab in childhood-onset systemic lupus erythematosus. [PDF]
Li Y +14 more
europepmc +1 more source

